1![Non-nucleoside reverse transcriptase inhibitors / Medicine / Pyridines / Bristol-Myers Squibb / Sulfonamides / Delavirdine / Reverse-transcriptase inhibitor / Antiretroviral drug / HIV / Chemistry / Organic chemistry / HIV/AIDS Non-nucleoside reverse transcriptase inhibitors / Medicine / Pyridines / Bristol-Myers Squibb / Sulfonamides / Delavirdine / Reverse-transcriptase inhibitor / Antiretroviral drug / HIV / Chemistry / Organic chemistry / HIV/AIDS](/pdf-icon.png) | Add to Reading ListSource URL: www.aidsinfonet.orgLanguage: English - Date: 2014-01-24 17:00:02
|
---|
2![Kentucky Department for Medicaid Services ProDUR Severity Level I Drug-to-Drug (DD) Interactions The following chart lists severity level I drug-to-drug interactions and recommendations for point-of-sale (POS) editing s Kentucky Department for Medicaid Services ProDUR Severity Level I Drug-to-Drug (DD) Interactions The following chart lists severity level I drug-to-drug interactions and recommendations for point-of-sale (POS) editing s](https://www.pdfsearch.io/img/dc7a887461d6656f0f0670526394fe83.jpg) | Add to Reading ListSource URL: kyportal.magellanmedicaid.comLanguage: English - Date: 2011-01-26 14:53:22
|
---|
3![Kentucky Department for Medicaid Services Drug Management Review Advisory Board (DMRAB) Recommendations for Consideration The following chart provides a summary of the recommendations that were made by the Drug Managemen Kentucky Department for Medicaid Services Drug Management Review Advisory Board (DMRAB) Recommendations for Consideration The following chart provides a summary of the recommendations that were made by the Drug Managemen](https://www.pdfsearch.io/img/76562984311bdc52aef61bd01e2d6930.jpg) | Add to Reading ListSource URL: kyportal.magellanmedicaid.comLanguage: English - Date: 2011-12-02 10:31:32
|
---|
4![Kentucky Department for Medicaid Services ProDUR Severity Level I Drug-to-Drug (DD) Interactions The following chart lists severity level I drug-to-drug interactions and recommendations for point-of-sale (POS) editing s Kentucky Department for Medicaid Services ProDUR Severity Level I Drug-to-Drug (DD) Interactions The following chart lists severity level I drug-to-drug interactions and recommendations for point-of-sale (POS) editing s](https://www.pdfsearch.io/img/7a63f3b707c73d3b085ca14390f1bad9.jpg) | Add to Reading ListSource URL: kyportal.magellanmedicaid.comLanguage: English - Date: 2011-04-22 13:12:22
|
---|
5![These highlights do not include all the information needed to use LEXIVA safely and effectively. See full prescribing information for LEXIVA.LEXIVA (fosamprenavir calcium) Tablets, for oral useLEXIVA (fosamprenavir calci These highlights do not include all the information needed to use LEXIVA safely and effectively. See full prescribing information for LEXIVA.LEXIVA (fosamprenavir calcium) Tablets, for oral useLEXIVA (fosamprenavir calci](https://www.pdfsearch.io/img/2e29b8effa975ded2e0e078dbb2d9aa7.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
6![Kansas Ryan White ADAP Formulary HIV Anti‐Retroviral Non‐Nucleoside Reverse Transcriptase Inhibitors (NNRTI) Generic Name Brand Name delavirdine mesylate Kansas Ryan White ADAP Formulary HIV Anti‐Retroviral Non‐Nucleoside Reverse Transcriptase Inhibitors (NNRTI) Generic Name Brand Name delavirdine mesylate](https://www.pdfsearch.io/img/9f14073f55adb423bf2b918645a32a26.jpg) | Add to Reading ListSource URL: www.kdheks.govLanguage: English - Date: 2014-12-03 10:35:25
|
---|
7![](https://www.pdfsearch.io/img/2875e9828207378fced23fd3ee5ea800.jpg) | Add to Reading ListSource URL: epi.ncpublichealth.comLanguage: English - Date: 2014-05-28 13:45:01
|
---|
8![----------------------- WARNINGS AND PRECAUTIONS ---------------• Certain drugs should not be coadministered with LEXIVA due to risk of serious or life-threatening adverse reactions. (5.1) • LEXIVA should be discon ----------------------- WARNINGS AND PRECAUTIONS ---------------• Certain drugs should not be coadministered with LEXIVA due to risk of serious or life-threatening adverse reactions. (5.1) • LEXIVA should be discon](https://www.pdfsearch.io/img/4adf066ba99e20768c849f1cac04414b.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-09-18 15:40:59
|
---|
9![Microsoft Word - narc-int Microsoft Word - narc-int](https://www.pdfsearch.io/img/bfca6e7f2c102016d095583175871536.jpg) | Add to Reading ListSource URL: www.hivclinic.caLanguage: English - Date: 2014-09-19 13:57:25
|
---|
10![Microsoft Word - benzo-int.doc Microsoft Word - benzo-int.doc](https://www.pdfsearch.io/img/fb95d0b3a0fba1084c362b19fd66b6af.jpg) | Add to Reading ListSource URL: www.hivclinic.caLanguage: English - Date: 2013-11-04 13:42:07
|
---|